What are major acquisitions that AMCOR has done in FY2023, FY2022 and FY2021?
On August 1, 2022, the Company completed the acquisition of 100% equity interest in a Czech Republic company that operates a world-class
flexible packaging manufacturing plant. The purchase consideration of $59 million included a deferred portion of $5 million that was paid in the
first quarter of fiscal year 2024. The acquisition is part of the Company's Flexibles reportable segment and resulted in the recognition of acquired
identifiable net assets of $36 million and goodwill of $23 million. Goodwill is not deductible for tax purposes. The fair values of the identifiable
net assets acquired and goodwill are based on the Company's best estimate as of June 30, 2023.
 On March 17, 2023, the Company completed the acquisition of 100% equity interest in a medical device packaging manufacturing site in
Shanghai, China. The purchase consideration of $60 million is subject to customary post-closing adjustments. The consideration includes
contingent consideration of $20 million, to be earned and paid in cash over the three years following the acquisition date, subject to meeting
certain performance targets. The acquisition is part of the Company's Flexibles reportable segment and resulted in the recognition of acquired
identifiable net assets of $21 million and goodwill of $39 million. Goodwill is not deductible for tax purposes. The fair values of the contingent
consideration, identifiable net assets acquired, and goodwill are based on the Company's best estimate as of June 30, 2023, and are considered
preliminary. The Company aims to complete the purchase price allocation as soon as practicable but no later than one year from the date of the
acquisition.
 On May 31, 2023, the Company completed the acquisition of a New Zealand based leading manufacturer of state-of-the-art, automated protein
packaging machines. The purchase consideration of $45 million is subject to customary post-closing adjustments. The consideration includes
contingent consideration of $13 million, to be earned and paid in cash over the two years following the acquisition date, subject to meeting
certain performance targets. The acquisition is part of the Company's Flexibles reportable segment and resulted in the recognition of acquired
identifiable net assets of $9 million and goodwill of $36 million. Goodwill is deductible for tax purposes. The fair values of the contingent
consideration, identifiable net assets acquired, and goodwill are based on the Company's best estimate as of June 30, 2023, and are considered
preliminary. The Company aims to complete the purchase price allocation as soon as practicable but no later than one year from the date of the
acquisition.
Amcor completed these acquisitions during FY2023:
-100% equity interest of a flexibles manufacturing company in the Czech Republic
- 100% equity interest in a medical device packaging manufacturing site in
Shanghai, China.
-acquisition of a New Zealand-based leading manufacturer of state-of-the-art, automated protein
packaging machines.